OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
March 02, 2011
A single, global tooling standard would offer many benefits, but one has been slow to emerge.
The author provides an overview of QbD implmentation for biopharmaceuticals.
The authors outline the key decision points FDA must consider in putting forth a US regulatory pathway for biosimilars.
February 24, 2011
HHS Releases a New National Vaccine Plan
February 16, 2011
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the February 2011 edition from Alfa Laval and GE Healthcare.
February 11, 2011
The application of the first piston syringes to treat medical complications was described in Roman times during the 1st century, and forms of intravenous injection and infusion began as early as 1670.
February 02, 2011
Deep process characterization and "lab-on-a-chip" enable SMART bioprocess design.
January 20, 2011
FDA issued a draft guidance for industry on Jan. 18, 2011, about the size of beads within drug products labeled for sprinkle.
January 19, 2011
A company's contamination-control plan is an important document designed to formalize the rationale, methods, and validation of contamination-control procedures in a manufacturing facility. The author describes the role of bioburden in the contamination-control plan.
Improvements in analytical techniques may call for a re-evaluation of the biopharmaceutical industry saying that "the process is the product."